Long Acting Injectables Explained - Info Session with Indivior + Camurus

Friday  19 July  2019  9:30 AM    Friday  19 July  2019 12:00 PM
Save Saved
Last update 20/07/2019
  3314

Dear colleagues

As you are aware there are two new long-acting-injectable buprenorphine (LAI-B) products available in Australia:

1) Sublocade, by Indivior

2) Buvidal, by Camurus

Due to high level of interest in these new products, Insight is coordinating a free seminar/webinar featuring representatives from both Camurus and Indivior who will be providing an overview of their respective products.

Each session will cover:

  • Technology behind the LAIs

  • Pharmacokinetics

  • Dosage / strengths / injection volumes

  • Storage requirements

  • Blockade of LAI

  • Conversion of patients from Methadone / Suboxone to LAI

  • Dosing windows

  • Demonstration of administration / video

  • Costs / benefits for patients

This event can be attended in person or as an online webinar. Registration is required for both options - please select the ticket type applicable to you during the registration. 

Webinar participants will be emailed a special link to the webinar in the days preceding the event.

NB: Registration is limited to Qld-based AOD health workers only, and priority will be given to staff employed within OST clinics.

Please note, this webinar will not be film-recorded, and is not catered (tea and coffee available only).

We hope you can join us!

Kind regards

Insight: Centre for AOD Training and Workforce Development

cinema sports
Nearby hotels and apartments
Biala Community Health Building
Edwards-Miller Conference Room, 4th Floor, Brisbane, 4000, QLD, Australia
Biala Community Health Building
Edwards-Miller Conference Room, 4th Floor, Brisbane, 4000, QLD, Australia
Event from eventbrite.com.au